The global behavioral rehabilitation market was valued at USD 155.55 billion in 2022 and is expected to reach USD 235.84 billion by 2032, poised to grow at a compound annual growth rate (CAGR) of 4.3% during the forecast period 2023 to 2032.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The rising prevalence of various mental disorders such as depression, anxiety, and attention deficit disorders are the primary drivers of the global behavioral rehabilitation market. According to the Mental Health Foundation, the most severe cause of increasing medical concerns is the mental health disorders. According to the US Department of Health and Human Services, around 20% of the children and adolescents suffered from mental disorders in their life at some point of time. Around 10% of people suffered from severe emotional disorders at some point in their life. Therefore, the rising cases of mental disorders across the globe is a major factors that propels the growth of the global behavioral rehabilitation market. Moreover, the rising number of service providers, growing expenditure on healthcare, and rising awareness regarding the mental health disorders among the population are several important factors that fosters the market growth across the globe.
The gap between the demand and supply of the behavioral rehabilitation services is huge in majority of the regions and the growth potential is higher for the market participants. Furthermore, the rising incidence of drug addiction among the youngsters is fostering the demand for the behavioral rehabilitation services. According to the United Nations Office on Drugs and Crime,in 2013, around 27 million people were suffering from drug use disorder. Around 24% to 36% of the heroin consuming population passes through correctional system annually in US. Furthermore, the rising prevalence of HIV among the population who injects drug is a significant factor behind the increased demand for the behavioral rehabilitation services. The increasing participation of government and the NGOs in spreading the awareness regarding the mental disorders is expected to fuel the growth of the behavioral rehabilitation market across the globe. The advancements in the field of various therapies like cognitive behavioral therapy is playing a crucial role in the development of the market.
| Report Highlights | Details |
| Market Size in 2023 | USD 161.46 Billion |
| Market Size by 2032 | USD 235.84 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 4.3% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | Disorder Type, Application |
| Regional Scope |
|
| Companies Mentioned | Allergan, Inc., Novartis AG, Taro Pharmaceutical Industries, Perrigo Company plc, Zynerba Pharmaceuticals, Apotex Inc., Sandoz AG, Strides Arcolab Ltd., TOLMAR Pharmaceuticals, Inc., Limbix |
Based on disorder type, the anxiety segment accounted the largest revenue share in 2022 and is estimated to remain its dominance during the forecast period. According to a study, in 2017, around 284 million people were estimated to be suffering from anxiety disorder, globally. According to the Anxiety and Depression Association of America, around 18.1% of the US population aged 18 years or above suffers from anxiety each year. But only around 37% of the patients gets treatment. The availability of antidepressants and advancements in the field of anxiety treatment due to the constant research and development is expected to foster the growth of this segment during the forecast period.
On the other hand, the substance abuse disorders segment is expected to be the fastest-growing segment during the forecast period. This is owing to the rising penetration of illegal businesses and rising unemployment that leads to the addiction of drugs among the people. The drug of abuse is a major cause of the mental disorders and rising awareness regarding this is estimated to fuel the growth of this segment. Furthermore, the inefficiency of the government to curb the illegal business of drug of abuse especially in the developing and underdeveloped nations is expected to boost the number of drug addicts, which in turn will propel the demand for the behavioral rehabilitation services across the globe.
Based on application, the outpatient segment accounted the largest revenue share in 2022 and is estimated to remain its dominance over the forecast period. This is attributed to the conveniences it provides to the patients. In the outpatient treatment the patient is allowed to return to their homes after attending treatment services regularly. The flexibility associated with the outpatient care makes it favorable for those patients who are at the initial stage of the mental health disorder. This factor makes this the fastest-growing segment too. However, the treatment of substance abuse patient is considered to be ineffective in this type of care. This is so because, the patient, after receiving the treatment can again go back to their home and friends and can consume drugs.
Based on region, North America accounted for over 40% of the market share in 2022 and is expected to sustain its dominance during the forecast period. North America is characterized by the increased prevalence of mental health disorders such as anxiety, depression, and attention deficit disorders. The increased awareness regarding the availability of behavioral rehabilitation services, increased awareness among the population regarding mental health disorders, rising government initiatives to spread awareness regarding the rehabilitation services, and increased consumer expenditure on healthcare. All these are the significant factors that has propelled the growth of the behavioral rehabilitation market in North America in the past few years. Moreover, the recent outbreak of the COVID-19 pandemic resulted in increased unemployment and reduced income, which has increased the prevalence of various mental disorders like anxiety and depressions among the population. Hence, COVID-19 influenced the market growth in 2020, in North America to a great extents.
On the other hand, Asia Pacific is estimated to be the fastest-growing market during the forecast period. This is due to the rising consumer awareness regarding the mental disorders, increasing number of rehabilitation centers, increasing consumer expenditure on healthcare, and rising incidences of drug addiction among the youth. The rise in the consumption of illicit drugs among the young population is expected to boost the growth of the market in the forthcoming years, as consumption of illicit drugs results in various mental health disorders.
Key Companies & Market Share Insights
The market is moderately fragmented with the presence of several local companies. These market players are striving to gain higher market share by adopting strategies, such as investments, partnerships, and acquisitions & mergers. Companies are also spending on the development of improved products. Moreover, they are also focusing on maintaining competitive pricing.
In May 2020, Limbix received around US$ 9 million in series a funding, which will be utilized to develop digital therapeutics for the teens who are suffering from depression.
The various developmental strategies like acquisition, partnerships, mergers, and government policies fosters market growth and offers lucrative growth opportunities to the market players.
Segments Covered in the Report
By Disorder Type
By Application
By Geography
PROCEED TO BUY :
ASK FOR SAMPLE
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
